Neuropsychologic aspects of post-traumatic headache and chronic daily headache

Branca, Barbaranne

doi:10.1007/s11916-006-0010-6

Cited by 8 publications

(4 citation statements)

References 64 publications

(53 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other risk factors for developing chronic PTHA include female gender, lower socioeconomic status, and prior history of headaches [7,8,10,11,15]. Psychiatric disorders are increased in patients with PTHA and contribute to headache chronicity, headache frequency, and headache-related disability [16][17][18][19].…”

Section: Introductionmentioning

confidence: 99%

Posttraumatic Headache in Military Personnel and Veterans of the Iraq and Afghanistan Conflicts

Theeler

Erickson

2011

Curr Treat Options Neurol

View full text Add to dashboard Cite

Headaches, particularly migraine, are common in US servicemembers (SMs) who are deployed to or have returned from theaters of combat operations in Iraq and Afghanistan. Concussions and exposure to explosive blasts may be a significant contributor to the increased prevalence of headaches in military veterans. Concussions, usually due to blast exposure, occur in approximately 20% of deployed SMs, and headaches are a common symptom after a deployment-related concussion. Posttraumatic headaches (PTHAs) in US SMs usually resemble migraines, and posttraumatic stress disorder (PTSD) and depression are common comorbidities. Treatment of PTHAs in SMs is based upon the treatment setting, whether the headaches are acute or chronic, the headache phenotype, and associated comorbidities. No randomized, controlled clinical trials evaluating the efficacy of therapies for PTHAs have been completed. Pharmacologic and nonpharmacologic management strategies should be selected on an individual basis. Acute therapy with NSAIDs or triptans and prophylactic therapy in acute and chronic settings using valproate, nortriptyline, amitriptyline, propranolol, topiramate, or botulinum toxin are discussed. Triptans and topiramate may be particularly effective in SMs with PTHA. Management of PTHA and other features of the posttraumatic syndrome should be multidisciplinary whenever possible.

show abstract

Section: Introductionmentioning

confidence: 99%

Posttraumatic Headache in Military Personnel and Veterans of the Iraq and Afghanistan Conflicts

Theeler

Erickson

2011

Curr Treat Options Neurol

View full text Add to dashboard Cite

show abstract

“…Notably, virtually all acquired or secondary neurological diseases of the nervous system, including traumatic, vascular, infectious, inflammatory, demyelinating, tumor, iatrogenic, toxic, metabolic, and psychiatric disorders have been associated with intellectual impairment or dementia [12]. Likewise, some systemic diseases, such as chronic pain [13] or rheumatic [14] and digestive [15] conditions, have been associated with cognitive dysfunction. Therefore, the ubiquity of intellectual dysfunction in human pathology and the fact that cognitive impairment is always a major cause of disability for the patient highlights the importance of the problem and the need to generate knowledge on the causes, pathogenetic mechanisms, and treatments of these disorders.…”

Section: Of 29mentioning

confidence: 99%

Methods to Identify Cognitive Alterations from Animals to Humans: A Translational Approach

Navarro

Gasparyan

Martínez

et al. 2023

IJMS

View full text Add to dashboard Cite

The increasing prevalence of cognitive dysfunction and dementia in developed countries, associated with population aging, has generated great interest in characterizing and quantifying cognitive deficits in these patients. An essential tool for accurate diagnosis is cognitive assessment, a lengthy process that depends on the cognitive domains analyzed. Cognitive tests, functional capacity scales, and advanced neuroimaging studies explore the different mental functions in clinical practice. On the other hand, animal models of human diseases with cognitive impairment are essential for understanding disease pathophysiology. The study of cognitive function using animal models encompasses multiple dimensions, and deciding which ones to investigate is necessary to select the most appropriate and specific tests. Therefore, this review studies the main cognitive tests for assessing cognitive deficits in patients with neurodegenerative diseases. Cognitive tests, the most commonly used functional capacity scales, and those resulting from previous evidence are considered. In addition, the leading behavioral tests that assess cognitive functions in animal models of disorders with cognitive impairment are highlighted.

show abstract

“…6,8,9,11,29 Although a causal relationship has not been proven, psychiatric symptoms, such as depression, anxiety, anger, and personality change, are increased in patients with PTHA and may contribute to the development of chronic PTHA and increased headache-related disability. [30][31][32][33][34] PATHOPHYSIOLOGY The major neuroanatomic pathways involved in head pain are shown in Figure 4-2. The trigeminal nerve is the major peripheral nerve for transmitting pain stimuli of the head.…”

Section: Case 4-1mentioning

confidence: 99%

“…23,52 Cognitive impairment, primarily involving executive dysfunction as well as attentional deficits, memory impairment, and increased impulsivity, is another feature often seen in patients with chronic PTHA. 31,34,53 The prevalence of psychiatric comorbidities differs according to injury severity, duration from injury, and diagnostic criteria. Major depression in TBI has been reported in a wide range of 10% to 77%.…”

Section: Comorbiditiesmentioning

confidence: 99%

Posttraumatic Headache

Erickson¹,

Neely²,

Theeler³

2010

CONTINUUM: Lifelong Learning in Neurology

View full text Add to dashboard Cite

Headache is a common symptom after traumatic head injury and is a frequent feature of the postconcussive syndrome. A variety of headache subtypes can be precipitated by head trauma, although posttraumatic headaches most often resemble migraine or tension-type headache. A lack of clinical trials limits evidence-based treatment recommendations for both acute and chronic posttraumatic headaches. However, numerous pharmacologic and nonpharmacologic interventions can be used to successfully manage posttraumatic headaches. This article reviews the classification, epidemiology, prognosis, and pathophysiology of headaches after head trauma and provides a practical clinical approach for evaluating and treating patients with posttraumatic headaches.

show abstract

Neuropsychologic aspects of post-traumatic headache and chronic daily headache

Cited by 8 publications

References 64 publications

Posttraumatic Headache in Military Personnel and Veterans of the Iraq and Afghanistan Conflicts

Posttraumatic Headache in Military Personnel and Veterans of the Iraq and Afghanistan Conflicts

Methods to Identify Cognitive Alterations from Animals to Humans: A Translational Approach

Posttraumatic Headache

Contact Info

Product

Resources

About